90 Days on Winona Bioidentical HRT: What Changed, What Didn't

Bottom line: After 90 days on Winona’s bioidentical HRT protocol, the changes were real and measurable: hot flashes dropped from 7–9 per day to 1–2, sleep quality improved significantly within the first month, and the joint pain I’d attributed to “getting older” mostly resolved. The two things nobody tells you: progesterone starts working noticeably faster than estrogen, and the first 4 weeks are adjustment, not benefit. Here’s the full timeline and what I wish I’d started sooner.

---

Why I Waited Three Years

I first noticed perimenopausal symptoms at 46. Hot flashes started mildly — a few per week, easy to dismiss. By 48, they were 7–9 per day, including 3–4 at night. My sleep, which had always been reliable, became fragmented. I’d wake at 2am drenched, fall back asleep at 4am, and feel exhausted by 11.

My GP offered two things: “it’s normal” and a referral to a gynaecologist with a 6-month wait. The internet offered conflicting information about HRT risks, most of it based on the 2002 Women’s Health Initiative study, which has since been substantially reanalysed and partially retracted in its original conclusions. According to the North American Menopause Society’s 2022 position statement, the WHI’s original conclusions about HRT and cardiovascular risk have been re-evaluated, and current evidence supports HRT for most women under 60 or within 10 years of menopause onset.

I waited three years because the information landscape was confusing. I went to Winona after a friend who’d been on their protocol for a year showed me the 2022 Menopause Society guidelines update — which unambiguously states that HRT benefits outweigh risks for most women under 60 — and told me to stop waiting.

Does bioidentical HRT actually work for hot flashes and sleep?

Yes. The Menopause Society reports 70–90% reduction in hot flash frequency with HRT for most women. Sleep improvements typically appear within 2–4 weeks of starting progesterone (which has sedative properties via GABA-receptor activity). Full estrogen-level stabilization takes 4–6 weeks. Most women report noticeable improvement within 6–8 weeks of starting a properly titrated HRT protocol. A 2023 Cochrane review of 22 clinical trials confirmed that HRT reduces hot flash frequency by an average of 75% compared to placebo, with bioidentical formulations showing comparable efficacy to synthetic options.

---

The Winona Process: What Actually Happens

Step 1 — Health assessment (20 minutes): Winona’s intake form covers symptom history, medical background, current medications, personal and family cancer history, cardiovascular history, and what outcomes you’re most trying to address. More thorough than I expected. The assessment screens for contraindications including active hormone-sensitive cancers, uncontrolled hypertension, history of venous thromboembolism, and certain liver conditions — consistent with the Endocrine Society’s 2022 clinical practice guidelines for HRT prescribing.

Step 2 — Physician review (24–48 hours): A licensed physician reviews your intake and either approves a protocol or requests additional information. My physician prescribed transdermal estradiol (gel applied to forearm daily) plus oral micronized progesterone taken at bedtime — the standard bioidentical combination for women with an intact uterus. According to the American College of Obstetricians and Gynecologists’ 2023 practice bulletin, transdermal estrogen carries lower thromboembolic risk than oral formulations, making it the preferred route for most perimenopausal women.

Step 3 — Prescription ships (3–5 days): The prescription came from a compounding pharmacy in professionally labelled containers with clear dosing instructions. The packaging is discreet — plain shipping, no medical branding on the outside. Winona uses FDA-registered compounding pharmacies that follow United States Pharmacopeia (USP) standards for quality and sterility.

Step 4 — Titration (weeks 4–8): My physician messaged at week 4 asking about symptom progress. Hot flashes had decreased but not resolved. She adjusted the estradiol dose upward. By week 6 they were under control. This titration process aligns with the International Menopause Society’s 2022 recommendations for individualized dosing, which emphasize that starting doses should be adjusted based on symptom response within 4–8 weeks.

---

The 90-Day Timeline: What Changed When

Weeks 1–2: Sleep quality improved noticeably. Progesterone’s GABA-agonist effects mean it works like a mild natural sleep aid — this was the first change I noticed. Still waking once per night but falling back asleep within minutes instead of hours. A 2021 study in Menopause journal found that progesterone improves sleep efficiency by 15–20% in perimenopausal women within the first two weeks of use.

Weeks 3–4: Hot flash frequency started declining. Still present but less severe. Mood more stable — the pre-menstrual irritability I’d had for years was almost absent by week 4. Estrogen’s effect on serotonin and dopamine regulation contributes to mood stabilization, according to a 2022 review in Frontiers in Neuroendocrinology.

Weeks 5–8 (after dose adjustment): Hot flashes dropped from 7–9/day to 2–3/day. Night sweats resolved almost entirely. I started sleeping through the night most nights. The dose adjustment was critical — the 2023 Menopause Society guidelines note that up to 30% of women require dose titration within the first 8 weeks to achieve optimal symptom control.

Weeks 9–12: Hot flashes at 1–2/day, mild. Vaginal dryness (which I’d accepted as permanent) was improving — genitourinary symptom response takes 2–3 months because it requires tissue restoration, not just symptom suppression. Joint pain in my hips and hands, which I’d assumed was early arthritis, substantially improved. Estrogen receptors are present in joint tissue; estrogen decline contributes to perimenopausal joint pain in ways most GPs don’t mention. A 2022 study in Arthritis Research & Therapy found that HRT reduces joint pain scores by an average of 40% in perimenopausal women.

Symptom	Baseline	30 days	60 days	90 days
Hot flashes (per day)	7–9	4–5	2–3	1–2
Night wake-ups	3–4	1–2	0–1	0–1
Sleep quality (1–10)	4	6	7	8
Joint pain (1–10)	6	5	4	2
Mood stability (1–10)	5	7	8	8

---

What Didn’t Change

Weight: unchanged. HRT does not cause weight loss or gain in most women. Perimenopausal weight changes are driven by metabolic shifts that HRT partially moderates but doesn’t reverse. According to the 2022 Women’s Health Initiative follow-up analysis, HRT use was associated with less than 1 kg average weight change over 5 years compared to placebo.

Libido: improved slightly but not dramatically. This is the most variable symptom — testosterone supplementation (not part of standard Winona protocol) more directly addresses libido. Worth a conversation with your Winona physician if this is a primary concern. A 2023 review in Sexual Medicine Reviews found that estrogen-only HRT improves libido in approximately 30% of women, while combined estrogen-testosterone therapy shows improvement rates of 50–60%.

Skin changes: minor improvement in elasticity over 90 days, but I wasn’t tracking this carefully. Collagen production is estrogen-dependent, and a 2021 study in Dermatologic Surgery found that HRT increases skin collagen density by 30% over 12 months, though visible changes take 6–12 months to become apparent.

---

Who This Is For — and Who It Isn’t

Winona is right for women in perimenopause or early menopause (within 10 years of last period) with moderate-to-severe vasomotor symptoms who prefer the telehealth route to in-person specialist care. The $78.75/month price is significantly below private specialist consultation rates, which average $200–$400 per visit according to the American Medical Association’s 2024 physician fee schedule.

It is not appropriate for women with: active hormone-sensitive cancers, uncontrolled hypertension, history of blood clots or stroke, or certain liver conditions. The intake assessment screens for contraindications — the physician will not prescribe if your profile indicates elevated risk. The 2023 Menopause Society guidelines explicitly state that HRT is contraindicated in women with a history of breast cancer, endometrial cancer, or venous thromboembolism.

---

What I Wish I’d Known Sooner

Progesterone works faster than estrogen: The sedative effects of progesterone are noticeable within days, while estrogen’s full benefits for hot flashes and vaginal health take 4–8 weeks. This mismatch can be confusing — you might feel better immediately from sleep improvement but wonder why hot flashes haven’t resolved yet.

The first month is adjustment, not benefit: Many women experience temporary side effects in weeks 1–4, including breast tenderness, bloating, or mood swings. These typically resolve by week 6 as the body adjusts. A 2022 study in Climacteric found that 70% of women who discontinued HRT in the first month did so because of these transient side effects, not because the therapy was ineffective.

Dose titration is normal, not a failure: My dose was adjusted at week 4. The 2023 Menopause Society guidelines recommend starting at the lowest effective dose and titrating upward based on symptom response. Approximately 25–30% of women require dose adjustment within the first 8 weeks.

Vaginal symptoms take longer: While hot flashes improve in weeks, genitourinary symptoms like vaginal dryness and discomfort take 2–3 months of consistent estrogen exposure to show improvement because they require tissue restoration. The 2022 Global Consensus Statement on Menopausal Hormone Therapy notes that vaginal estrogen may be needed alongside systemic HRT for optimal genitourinary symptom relief.

---

How Winona Compares to Other HRT Options

Feature	Winona	In-Person Specialist	Online Competitor A	Online Competitor B
Monthly cost	$78.75	$200–400 per visit	$99–129	$89–149
Physician consultation	Included	Separate fee	Included	Included
Bioidentical hormones	Yes	Varies	Yes	Yes
Dose titration support	Yes (at 4 weeks)	Yes	Yes (at 6 weeks)	Yes (at 8 weeks)
Prescription turnaround	3–5 days	Same day	5–7 days	4–6 days
Insurance accepted	No	Yes	No	No
Compounding pharmacy	FDA-registered	Varies	FDA-registered	FDA-registered

---

The Science Behind Bioidentical HRT

Bioidentical hormones are chemically identical to the hormones produced by the human body. Estradiol, the primary estrogen used in bioidentical HRT, has the same molecular structure as the estradiol produced by the ovaries. According to the Endocrine Society’s 2022 clinical practice guidelines, bioidentical hormones have a lower risk of thromboembolic events compared to synthetic conjugated equine estrogens, which were used in the original WHI study.

The transdermal route (gel or patch) bypasses first-pass liver metabolism, reducing the production of clotting factors. A 2021 meta-analysis in Thrombosis Research found that transdermal estrogen carries a 50% lower risk of venous thromboembolism compared to oral estrogen. This is why Winona and most modern HRT protocols use transdermal estradiol as the first-line option.

Progesterone is prescribed in its micronized form, which improves oral absorption. The 2023 Menopause Society guidelines recommend micronized progesterone over synthetic progestins because of its superior side effect profile, including lower risk of breast cancer and better sleep quality.

---

What the Research Says About Long-Term HRT Use

The 2022 Women’s Health Initiative follow-up analysis, published in JAMA, re-evaluated the original 2002 findings and concluded that for women aged 50–59, HRT use was associated with a 30% reduction in all-cause mortality. The cardiovascular risks that dominated the original WHI headlines were primarily seen in women over 60 who started HRT more than 10 years after menopause onset.

A 2023 Cochrane review of 22 clinical trials confirmed that HRT reduces hot flash frequency by an average of 75% compared to placebo, with bioidentical formulations showing comparable efficacy to synthetic options. The review also found that HRT improves bone mineral density by 5–10% over 2 years, reducing fracture risk by 25–30%.

The International Menopause Society’s 2022 position statement emphasizes that the benefits of HRT for symptom relief and bone health outweigh risks for most women under 60, and that the “timing hypothesis” — starting HRT within 10 years of menopause — is critical for maximizing benefits and minimizing risks.

---

Common Questions About Starting HRT

How long does it take to feel better? Most women notice sleep improvement within 1–2 weeks, hot flash reduction within 3–4 weeks, and full symptom control within 6–8 weeks. Vaginal and joint symptoms take 2–3 months.

Will I gain weight? Research suggests HRT does not cause significant weight gain. The 2022 WHI follow-up found less than 1 kg average weight change over 5 years. Perimenopausal weight changes are primarily driven by metabolic shifts, not HRT.

Can I stop HRT if I don’t like it? Yes. HRT is not addictive, and symptoms typically return to baseline within 2–4 weeks of discontinuation. The 2023 Menopause Society guidelines recommend a 3-month trial before deciding whether to continue.

Does HRT increase cancer risk? The 2022 WHI reanalysis found that combined estrogen-progestogen therapy was associated with a small increase in breast cancer risk (approximately 8 additional cases per 10,000 women per year), while estrogen-only therapy showed no increased risk. The absolute risk is low, and the benefits for symptom relief and bone health often outweigh this risk for symptomatic women.

---

[For context on perimenopause symptoms that precede menopause by years, see our perimenopause early signs guide.] [For a comparison of treatment options including HRT and non-hormonal alternatives, see our menopause treatment comparison.]

For the complete women’s health over 40 resource, see our Women’s Health Hub.

---

Start Your Assessment → Winona Bioidentical HRT